Literature DB >> 29107106

The role of nitric oxide in metabolic regulation of Dendritic cell immune function.

Phyu M Thwe1, Eyal Amiel2.   

Abstract

Dendritic cells (DCs) are canonical antigen presenting cells of the immune system and serve as a bridge between innate and adaptive immune responses. When DCs are activated by a stimulus through toll-like receptors (TLRs), DCs undergo a process of maturation defined by cytokine & chemokine secretion, co-stimulatory molecule expression, antigen processing and presentation, and the ability to activate T cells. DC maturation is coupled with an increase in biosynthetic demand, which is fulfilled by a TLR-driven upregulation in glycolytic metabolism. Up-regulation of glycolysis in activated DCs provides these cells with molecular building blocks and cellular energy required for DC activation, and inhibition of glycolysis during initial activation impairs both the survival and effector function of activated DCs. Evidence shows that DC glycolytic upregulation is controlled by two distinct pathways, an early burst of glycolysis that is nitric oxide (NO) -independent, and a sustained commitment to glycolysis in NO-producing DC subsets. This review will address the complex role of NO in regulating DC metabolism and effector function.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29107106      PMCID: PMC5699934          DOI: 10.1016/j.canlet.2017.10.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  120 in total

Review 1.  Innate control of adaptive immunity: dendritic cells and beyond.

Authors:  Heung Kyu Lee; Akiko Iwasaki
Journal:  Semin Immunol       Date:  2007-02-05       Impact factor: 11.130

2.  Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.

Authors:  Connie M Krawczyk; Thomas Holowka; Jie Sun; Julianna Blagih; Eyal Amiel; Ralph J DeBerardinis; Justin R Cross; Euihye Jung; Craig B Thompson; Russell G Jones; Edward J Pearce
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

3.  Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine.

Authors:  Kanako L Lewis; Michele L Caton; Milena Bogunovic; Melanie Greter; Lucja T Grajkowska; Dennis Ng; Apostolos Klinakis; Israel F Charo; Steffen Jung; Jennifer L Gommerman; Ivaylo I Ivanov; Kang Liu; Miriam Merad; Boris Reizis
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

Review 4.  Development and function of dendritic cell subsets.

Authors:  Alexander Mildner; Steffen Jung
Journal:  Immunity       Date:  2014-05-15       Impact factor: 31.745

5.  Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses.

Authors:  C A Bonham; L Lu; Y Li; R A Hoffman; R L Simmons; A W Thomson
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

6.  Hypoxia-inducible factor 1α modulates metabolic activity and cytokine release in anti-Aspergillus fumigatus immune responses initiated by human dendritic cells.

Authors:  Mirjam Fliesser; Charles Oliver Morton; Michael Bonin; Frank Ebel; Kerstin Hünniger; Oliver Kurzai; Hermann Einsele; Jürgen Löffler
Journal:  Int J Med Microbiol       Date:  2015-09-16       Impact factor: 3.473

7.  Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell development.

Authors:  Dachuan Huang; Deyu Tarika Cai; Rong Yuan Ray Chua; David Michael Kemeny; Siew Heng Wong
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

8.  Regulatory role of nitric oxide on monocyte-derived dendritic cell functions.

Authors:  Silvia Corinti; Saveria Pastore; Francesca Mascia; Giampiero Girolomoni
Journal:  J Interferon Cytokine Res       Date:  2003-08       Impact factor: 2.607

9.  Rat bone marrow-derived dendritic cells, but not ex vivo dendritic cells, secrete nitric oxide and can inhibit T-cell proliferation.

Authors:  Timothy J Powell; Chris D Jenkins; Ryuichi Hattori; G Gordon MacPherson
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 10.  mTORC1 and mTORC2 as regulators of cell metabolism in immunity.

Authors:  Monika Linke; Stephanie Deborah Fritsch; Nyamdelger Sukhbaatar; Markus Hengstschläger; Thomas Weichhart
Journal:  FEBS Lett       Date:  2017-06-23       Impact factor: 4.124

View more
  24 in total

Review 1.  Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.

Authors:  Debashree Basudhar; Gaurav Bharadwaj; Veena Somasundaram; Robert Y S Cheng; Lisa A Ridnour; Mayumi Fujita; Stephen J Lockett; Stephen K Anderson; Daniel W McVicar; David A Wink
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

2.  STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice.

Authors:  Ross J Darling; Sujata Senapati; Sean M Kelly; Marian L Kohut; Balaji Narasimhan; Michael J Wannemuehler
Journal:  Vaccine       Date:  2019-04-12       Impact factor: 3.641

Review 3.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 4.  Interplay Between Reactive Oxygen/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease.

Authors:  Masuko Ushio-Fukai; Dipankar Ash; Sheela Nagarkoti; Eric J Belin de Chantemèle; David J R Fulton; Tohru Fukai
Journal:  Antioxid Redox Signal       Date:  2021-06-01       Impact factor: 7.468

5.  Divergent Genetic Regulation of Nitric Oxide Production between C57BL/6J and Wild-Derived PWD/PhJ Mice Controls Postactivation Mitochondrial Metabolism, Cell Survival, and Bacterial Resistance in Dendritic Cells.

Authors:  Julia P Snyder; Soyeon K Gullickson; Roxana Del Rio-Guerra; Andrea Sweezy; Bay Vagher; Tyler C Hogan; Karolyn G Lahue; Julie A Reisz; Angelo D'Alessandro; Dimitry N Krementsov; Eyal Amiel
Journal:  J Immunol       Date:  2021-12-06       Impact factor: 5.426

6.  Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.

Authors:  Iris C Salaroglio; Elena Gazzano; Ahmad Abdullrahman; Eleonora Mungo; Barbara Castella; Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman; Massimo Massaia; Massimo Donadelli; Menachem Rubinstein; Chiara Riganti; Joanna Kopecka
Journal:  J Exp Clin Cancer Res       Date:  2018-11-27

7.  Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8+ T Cell Memory and Delayed Tumor Progression.

Authors:  Ross Darling; Sujata Senapati; John Christiansen; Luman Liu; Amanda E Ramer-Tait; Balaji Narasimhan; Michael Wannemuehler
Journal:  Int J Nanomedicine       Date:  2020-09-07

Review 8.  Effect of exosomal miRNA on cancer biology and clinical applications.

Authors:  Zhenqiang Sun; Ke Shi; Shuaixi Yang; Jinbo Liu; Quanbo Zhou; Guixian Wang; Junmin Song; Zhen Li; Zhiyong Zhang; Weitang Yuan
Journal:  Mol Cancer       Date:  2018-10-11       Impact factor: 27.401

9.  Presence of Infected Gr-1intCD11bhiCD11cint Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in Mycobacterium avium-Infected Mice.

Authors:  Ketema Abdissa; Andreas Nerlich; Andreas Beineke; Nanthapon Ruangkiattikul; Vinay Pawar; Ulrike Heise; Nina Janze; Christine Falk; Dunja Bruder; Ulrike Schleicher; Christian Bogdan; Siegfried Weiss; Ralph Goethe
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

Review 10.  Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.

Authors:  Renata Ramalho; Martin Rao; Chao Zhang; Chiara Agrati; Giuseppe Ippolito; Fu-Sheng Wang; Alimuddin Zumla; Markus Maeurer
Journal:  Semin Immunopathol       Date:  2020-06-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.